BII supports three international start-ups developing pioneering science in the therapeutics and health tech space
BII today announces its investment into three international start-up companies from the UK, Germany, and Finland. The three new ventures are strategically aligned with the BII’s focus, developing ground-breaking scientific initiatives across the therapeutics and health tech space.
